LAB Q4 2018 Earnings — Standard BioTools Inc. Revenue & Financial Results | Market Cap Arena

LABStandard BioTools Inc.

$370M

Q4 2018 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$32M+16.5% YoY

Gross Profit

$19M58.2% margin

Operating Income

-$11M-34.4% margin

Net Income

-$15M-45.7% margin

EPS (Diluted)

$-0.36

QoQ Revenue Growth

+11.6%

Cash Flow

Operating Cash Flow

-$638,000

Free Cash Flow

-$658,000

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$304M

Total Liabilities

$232M

Stockholders' Equity

$72M

Cash & Equivalents

$95M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$32M	$28M	+16.5%
Gross Profit	$19M	$14M	+31.7%
Operating Income	-$11M	-$9M	-27.3%
Net Income	-$15M	-$10M	-41.3%

Revenue Segments

Product

$27M46%

Instruments

$14M23%

Consumables

$13M23%

Service

$5M9%

Geographic Segments

Asia Pacific

$8M100%